Listen to this article

CMR Surgical Ltd. this week announced that it closed 2023 with a record number of Versius surgical robot installations in one quarter.

Founded in 2014, CMR Surgical said it closed the year with its Versius global install base more than 50% higher than in 2022. The Cambridge, U.K.-based company reported more than 17,000 procedures completed with the surgical robot during the year for growth of more than 60%.

Versius is a small-scale surgical robot featuring collaborative arms and bedside units for direct patient access. It also features offers of port placement to best suit the needs of each patient, said CMR Surgical in a release.

It designed Versius to enable surgeons to perform more minimally invasive procedures. The robot assists surgeons accessing the lungs, thymus, and esophagus.

Surgeons worldwide successfully use Versius

“Our team are experienced in doing complex urological robotic assisted surgeries for many years, and from the first 100 cases using Versius, I can say that switching from the surgical robot we were previously using to a Versius robot proved very easy and more efficient in several respects,” commented Thierry Rousseau, president of the Medical Committee at Clinique Urologique Nantes-Atlantis.

“The versatility of Versius has enabled us to perform complex procedures such as prostatectomies with ease, enabling us to adapt the surgical robot into our existing surgical practice with simplicity,” he said.

Expansion over 2023 included new markets such as Greece and Indonesia. In addition, CMR Surgical raised $165 million in September to support Versius.

Recent highlights include the latest Versius installation in Germany, noted CMR. There have been more than 140 around the world to date.

CMR Surgical aims to accelerate robot adoption

CMR Surgical said it plans to launch new technologies to further support the utilization of Versius in 2024. These technologies include vision, instrumentation, and digital enhancements. The company asserted that it aims to enter more new markets during the coming year.

New Chief Commercial Officer Massimiliano Colella is charged with leading the further acceleration of Versius installations, said CMR Surgical.

“As we enter our fifth year since the launch of Versius, this is a tremendously exciting time for CMR and our customers as we see the momentum for Versius, and robotic-assisted surgery grow exponentially,” stated Supratim Bose, CEO of CMR Surgical.

“Versius is a truly differentiated product that is helping more hospitals around the world offer robotic-assisted surgery,” he declared. “Additionally, the launch of new advanced technologies for Versius – across both hardware and software – will be a game-changer this year.

“We are already seeing Versius prove its use in complex surgeries, and with new products on the market, we look forward to working with our customers to expand the procedures that are performed using Versius, and welcome new hospitals in existing and new geographies, so that more patients can benefit from robotic-assisted surgery,” Bose said.

Editor’s note: This article was syndicated from MassDevice,  a sibling site to The Robot Report.